Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | | | | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Jan-22 | Jan-23 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 6,092 | 7,884 | 8,647 | 8,458 | 8,844 | 9,466 | 10,682 | | 10,891 |
% Growth | NA | NA | NA | NA | 29.4% | 9.7% | -2.2% | 4.6% | 7.0% | 12.8% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | (5,463) | (7,265) | (7,869) | (7,841) | (8,259) | (8,863) | (9,797) | | (9,982) |
Gross Profit | 0 | 0 | 0 | 629 | 620 | 778 | 617 | 585 | 603 | 885 | | 909 |
% Revenue | NA | NA | NA | 10.3% | 7.9% | 9.0% | 7.3% | 6.6% | 6.4% | 8.3% | | 8.3% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (3) | | (3) |
Selling and Marketing | 0 | 0 | 0 | (1) | (1) | (1) | (2) | (1) | (1) | (3) | | (4) |
General and Admin | 0 | 0 | 0 | (131) | (143) | (131) | (144) | (169) | (193) | (215) | | (221) |
Other Inc / (Exp) | 0 | 0 | 0 | (20) | (26) | (44) | (26) | 18 | 59 | 40 | | 50 |
Total Operating Exp | 0 | 0 | 0 | (152) | (170) | (176) | (171) | (152) | (135) | (181) | | (178) |
| | | | | | | | | | | | |
Operating Income | 0 | 0 | 0 | 477 | 449 | 602 | 446 | 433 | 468 | 704 | | 731 |
% Revenue | NA | NA | NA | 7.8% | 5.7% | 7.0% | 5.3% | 4.9% | 4.9% | 6.6% | | 6.7% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 105 | 162 | 161 | 40 | 97 | 96 | 96 | | 81 |
Pre-tax Income | 0 | 0 | 0 | 582 | 612 | 763 | 486 | 530 | 564 | 799 | | 813 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | (188) | (210) | (195) | (133) | (139) | (145) | (172) | | (202) |
Net Income to Company | 0 | 0 | 0 | 394 | 402 | 568 | 353 | 391 | 418 | 627 | | 611 |
% Margin | NA | NA | NA | 6.5% | 5.1% | 6.6% | 4.2% | 4.4% | 4.4% | 5.9% | | 5.6% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 0 | 0 | 0 | 394 | 402 | 568 | 353 | 391 | 418 | 627 | | 611 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 0 | 0 | 0 | 394 | 402 | 568 | 353 | 391 | 418 | 627 | | 611 |
% Margin | NA | NA | NA | 6.5% | 5.1% | 6.6% | 4.2% | 4.4% | 4.4% | 5.9% | | 5.6% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.09 | 0.09 | 0.09 | 0.14 | | 0.14 |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.09 | 0.09 | 0.09 | 0.14 | | 0.14 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,056.46 | 3,921.84 | 4,341.61 | 4,646.30 | 4,478.63 | | 4,353.53 |
WA Diluted Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,056.46 | 3,921.84 | 4,341.61 | 4,646.30 | 4,478.63 | | 4,353.53 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | 0 | 0 | 582 | 612 | 763 | 486 | 530 | 564 | 799 | | 813 |
Addback: Net Interest Expense | 0 | 0 | 0 | (105) | (162) | (161) | (40) | (97) | (96) | (96) | | (81) |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 1 | 1 | (0) | (29) | (30) | (37) | | (16) |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 441 | 523 | 570 | 579 | 598 | 618 | 649 | | 671 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | (0) | (0) | (2) | (0) | (0) | (0) | | (36) |
Addback: Asset Writedown | 0 | 0 | 0 | 7 | 15 | 33 | 21 | (5) | (23) | (3) | | (3) |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | (3) | (2) | (3) | (6) | 3 | (15) | (19) | | (31) |
Adjusted EBITDA | 0 | 0 | 0 | 922 | 986 | 1,203 | 1,037 | 1,000 | 1,017 | 1,293 | | 1,315 |
% Margin | NA | NA | NA | 15.1% | 12.5% | 13.9% | 12.3% | 11.3% | 10.7% | 12.1% | | 12.1% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | 0 | 0 | 482 | 463 | 633 | 459 | 402 | 399 | 644 | | 644 |
% Margin | NA | NA | NA | 7.9% | 5.9% | 7.3% | 5.4% | 4.5% | 4.2% | 6.0% | | 5.9% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | 0 | 0 | 394 | 402 | 568 | 353 | 391 | 418 | 627 | | 611 |
Addback: Unusual Items | 0 | 0 | 0 | 4 | 12 | 30 | 13 | (2) | (39) | (22) | | (71) |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | (1) | (3) | (8) | (3) | 1 | 10 | 6 | | 18 |
Adjusted Net Income | 0 | 0 | 0 | 397 | 411 | 590 | 363 | 389 | 390 | 611 | | 558 |
% Margin | NA | NA | NA | 6.5% | 5.2% | 6.8% | 4.3% | 4.4% | 4.1% | 5.7% | | 5.1% |